Plasmin degradation of fibrin coatings on synthetic polymer substrates.

The goal of this research was to evaluate the in vitro stability of fibrin coatings on polymeric materials in the presence of plasmin. Factor XIIIa-crosslinked and noncrosslinked fibrin layers were coated on three different polyurethane substrates: Corethane, Tegaderm, and a biodegradable polyurethane, PCL/HDI/Phe. Degradation assays indicated that crosslinking the fibrin coatings enhanced the stability of the coatings on both Tegaderm and PCL/HDI/Phe; however, the persistence of the coating on the woven Corethane was not influenced by crosslinking. Degradation assay results also showed that the fibrin coating on the Corethane was significantly less stable than the fibrin coatings on the Tegaderm and PCL/HDI/Phe films. The chromogenic substrate assay data showed crosslinking did not affect the specific plasmin activity on the coatings; therefore, the increased stability resulting from crosslinking was not achieved through a reduction of fibrinolysis. The plasmin activity on the coated Corethane samples was much greater than that on either of the coated flat wound dressing materials. The large surface area of Corethane, a porous woven vascular graft material, may have had a direct influence on the fibrinolysis of its coatings by providing a large number of tissue-type plasminogen activator (tPA) binding sites. A thin, crosslinked, fibrin-coated polyurethane provides a theoretically attractive biomaterial for use in a wound dressing application and should be subject to ongoing research.

[1]  K. Woodhouse,et al.  Protein and platelet interactions with thermally denatured fibrinogen and cross-linked fibrin coated surfaces. , 1998, Biomaterials.

[2]  K. Woodhouse,et al.  Synthesis and characterization of degradable polyurethane elastomers containing and amino acid-based chain extender. , 1998, Journal of biomaterials science. Polymer edition.

[3]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[4]  M. Brittberg,et al.  Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. , 1997, Biomaterials.

[5]  M. R. Jackson,et al.  Tissue sealants: Current status, future potential , 1996, Nature Medicine.

[6]  J. Soria,et al.  The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome". , 1996, The Journal of clinical investigation.

[7]  Buddy D. Ratner,et al.  Biomaterials Science: An Interdisciplinary Endeavor , 1996 .

[8]  M. Packham,et al.  Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII , 1995, Thrombosis and Haemostasis.

[9]  C. V. van Blitterswijk,et al.  Biocompatibility of a biodegradable matrix used as a skin substitute: an in vivo evaluation. , 1994, Journal of biomedical materials research.

[10]  S. Serrano,et al.  Basic proteinases from Bothrops moojeni (caissaca) venom--II. Isolation of the metalloproteinase MPB. Comparison of the proteolytic activity on natural substrates by MPB, MSP 1 and MSP 2. , 1993, Toxicon : official journal of the International Society on Toxinology.

[11]  J. Brash,et al.  The Effect of Antithrombin III-Independent Thrombin Inhibitors and Heparin on Fibrin Accretion onto Fibrin-Coated Polyethylene , 1993, Thrombosis and Haemostasis.

[12]  M. Nesheim,et al.  Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. , 1992, The Journal of biological chemistry.

[13]  D. Gabriel,et al.  The effect of fibrin structure on fibrinolysis. , 1992, The Journal of biological chemistry.

[14]  J. Brash,et al.  Interactions of thermally denatured fibrinogen on polyethylene with plasma proteins and platelets. , 1992, Journal of biomedical materials research.

[15]  C. Reilly,et al.  Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution. , 1992, The Journal of biological chemistry.

[16]  J. Shainoff,et al.  Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking. , 1991, The Journal of biological chemistry.

[17]  D. Massel,et al.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.

[18]  M. Mayer,et al.  Biochemical and biological aspects of the plasminogen activation system. , 1990, Clinical biochemistry.

[19]  R. Fears Binding of plasminogen activators to fibrin: characterization and pharmacological consequences. , 1989, The Biochemical journal.

[20]  E. Lavie,et al.  Structural changes in fibrin clot associated with the proteolytic activity induced by tissue type plasminogen activator. An NMR study. , 1989, Biochimica et biophysica acta.

[21]  F. Castellino,et al.  Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Haber,et al.  Innovative approaches to plasminogen activator therapy. , 1989, Science.

[23]  H. Redl,et al.  Morphometric studies on wound healing after systemic administration of adriamycin and local application of fibrin sealant. Application of a new wound healing model using spongiosa implants. , 1986, Pathology, research and practice.

[24]  B. Norrman,et al.  Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. , 1985, European journal of biochemistry.

[25]  V. Marder,et al.  PLASMIN DEGRADATION OF CROSS‐LINKED FIBRIN * , 1983, Annals of the New York Academy of Sciences.

[26]  M. Hoylaerts,et al.  Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.

[27]  C. Francis,et al.  Detection of circulating crosslinked fibrin derivatives by a heat extraction-SDS gradient gel electrophoretic technique. , 1979, Blood.